Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beate Klimm

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Deutsches Arzteblatt International|February 2, 2013
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaBeate Klimm, Corinne Brillant, Nicole Skoetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study groupBeate Klimm, Jeremy Franklin, Harald Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupBeate Klimm, Thorsten Reineke, Heinz Haverkamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study GroupKarolin Behringer, Kai Breuer, Thorsten Reineke, et al.
Blood|August 11, 2011
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Michael Fuchs, Annette Pluetschow, et al.
Leukemia & Lymphoma|October 22, 2013
Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplantBastian von Tresckow, Horst Müller, Dennis A Eichenauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study groupDiana Wongso, Michael Fuchs, Annette Plütschow, et al.
Clinical Pharmacokinetics|March 23, 2007
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicityStefan Wilde, Alexander Jetter, Stephan Rietbrock, et al.
Blood|January 31, 2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Indra Thielen, Heinz Haverkamp, et al.
Haematologica|January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantationElisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Deutsches Arzteblatt International|February 2, 2013
The effect of specialized cancer treatment centers on treatment efficacy in Hodgkin's lymphomaBeate Klimm, Corinne Brillant, Nicole Skoetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Lymphocyte-depleted classical Hodgkin's lymphoma: a comprehensive analysis from the German Hodgkin study groupBeate Klimm, Jeremy Franklin, Harald Stein, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 6, 2005
Role of hematotoxicity and sex in patients with Hodgkin's lymphoma: an analysis from the German Hodgkin Study GroupBeate Klimm, Thorsten Reineke, Heinz Haverkamp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2005
Secondary amenorrhea after Hodgkin's lymphoma is influenced by age at treatment, stage of disease, chemotherapy regimen, and the use of oral contraceptives during therapy: a report from the German Hodgkin's Lymphoma Study GroupKarolin Behringer, Kai Breuer, Thorsten Reineke, et al.
Blood|August 11, 2011
Phase 2 study of rituximab in newly diagnosed stage IA nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Michael Fuchs, Annette Pluetschow, et al.
Leukemia & Lymphoma|October 22, 2013
Outcome and risk factors of patients with Hodgkin Lymphoma who relapse or progress after autologous stem cell transplantBastian von Tresckow, Horst Müller, Dennis A Eichenauer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2013
Treatment-related mortality in patients with advanced-stage hodgkin lymphoma: an analysis of the german hodgkin study groupDiana Wongso, Michael Fuchs, Annette Plütschow, et al.
Clinical Pharmacokinetics|March 23, 2007
Population pharmacokinetics of the BEACOPP polychemotherapy regimen in Hodgkin's lymphoma and its effect on myelotoxicityStefan Wilde, Alexander Jetter, Stephan Rietbrock, et al.
Blood|January 31, 2014
Therapy-related acute myeloid leukemia and myelodysplastic syndromes in patients with Hodgkin lymphoma: a report from the German Hodgkin Study GroupDennis A Eichenauer, Indra Thielen, Heinz Haverkamp, et al.
Haematologica|January 10, 2013
Prognosis of patients with primary central nervous system lymphoma after high-dose chemotherapy followed by autologous stem cell transplantationElisabeth Schorb, Benjamin Kasenda, Johannes Atta, et al.
Pageof 3